These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9566979

  • 1. Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction.
    Nykjaer A, Christensen EI, Vorum H, Hager H, Petersen CM, Røigaard H, Min HY, Vilhardt F, Møller LB, Kornfeld S, Gliemann J.
    J Cell Biol; 1998 May 04; 141(3):815-28. PubMed ID: 9566979
    [Abstract] [Full Text] [Related]

  • 2. Structure of uPAR, plasminogen, and sugar-binding sites of the 300 kDa mannose 6-phosphate receptor.
    Olson LJ, Yammani RD, Dahms NM, Kim JJ.
    EMBO J; 2004 May 19; 23(10):2019-28. PubMed ID: 15085180
    [Abstract] [Full Text] [Related]

  • 3. Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR.
    Kreiling JL, Byrd JC, Deisz RJ, Mizukami IF, Todd RF, MacDonald RG.
    J Biol Chem; 2003 Jun 06; 278(23):20628-37. PubMed ID: 12665524
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of mannose 6-phosphate receptors and their ligands during the myogenic development of C2 cells.
    Szebenyi G, Rotwein P.
    J Biol Chem; 1991 Mar 25; 266(9):5534-9. PubMed ID: 1848553
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M.
    Biochemistry; 1998 Nov 24; 37(47):16494-505. PubMed ID: 9843416
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA, Kaun C, Wojta J, Binder B, Bach LA.
    J Cell Physiol; 2003 Oct 24; 197(1):131-8. PubMed ID: 12942549
    [Abstract] [Full Text] [Related]

  • 9. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
    Chang MH, Kuo WW, Chen RJ, Lu MC, Tsai FJ, Kuo WH, Chen LY, Wu WJ, Huang CY, Chu CH.
    J Mol Endocrinol; 2008 Aug 24; 41(2):65-74. PubMed ID: 18495691
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation.
    Ploug M, Ostergaard S, Hansen LB, Holm A, Danø K.
    Biochemistry; 1998 Mar 17; 37(11):3612-22. PubMed ID: 9521680
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II.
    Duplomb L, Chaigne-Delalande B, Vusio P, Raher S, Jacques Y, Godard A, Blanchard F.
    Endocrinology; 2003 Dec 17; 144(12):5381-9. PubMed ID: 12959977
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 6-phosphate/insulin-like growth factor II receptor.
    Hartman MA, Kreiling JL, Byrd JC, MacDonald RG.
    FEBS J; 2009 Apr 17; 276(7):1915-29. PubMed ID: 19236480
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.